Clinical trials: HIV Infection, completed
HIV Infections, Gonorrhea
Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China
This study will evaluate the effectiveness of a physician training program, the Ai Shi Zi program, in improving HIV/sexually transmitted infection diagnosis, treatment, and management by Chinese physicians and in reducing the…
- Conditions
- HIV Infections, Gonorrhea, Chlamydia
- Trial name
- NCT00644150
- Testing
- Physician Ai Shi Zi training, Standard care, Patient risk-reduction counseling
- Where
- China
- Volunteers
- 1,373 people
- Sponsor
- University of California, Los Angeles
Integrase Inhibitors, HIV; HIV PROTEASE INHIB
Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.
While 3-drug regimens remain standard of care, concerns exist regarding the safety of multi-drug regimens taken for a lifetime. Problems with nucleoside analogue therapy prompted successful trials with ritonavir (RTV) boosted PI…
- Trial name
- RALDAR (NCT01258374)
- Testing
- Raltegravir, Darunavir
- Where
- Spain
- Volunteers
- 15 people
- Sponsor
- Hospital Clinic of Barcelona
HIV Testing
Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care
Because adolescents and young adults face markedly increased HIV risk yet frequently do not test, we propose to complete the Mobile Augmented Screening (MAS) tool designed to increase HIV testing, and to facilitate linkage to…
- Trial name
- MAS (NCT03939455)
- Testing
- Mobile Augmented Screening tool
- Where
- United States
- Volunteers
- 295 people
- Sponsor
- New York University
HIV Infections, Sexually Transmitted Diseases
Reducing HIV Risk Among Adolescents: Evaluating HEART for Teens
This study evaluates an educational web-based intervention designed to increase adolescent boys' and girls' motivation and skills to engage in safer sexual behavior (HEART: Health Education and Relationship Training).
- Trial name
- NCT03453515
- Testing
- HEART, Growing Minds
- Where
- United States
- Volunteers
- 226 people
- Sponsor
- North Carolina State University
Cytomegalovirus Retinitis, HIV Infections
A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir
To determine the pharmacokinetics (blood levels) of three dose treatment plans of oral ganciclovir during a 28-day dosing period.
- Trial name
- NCT00000668
- Testing
- Ganciclovir
- Where
- 5 sites in United States
- Volunteers
- 48 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
HAART Non-Adherence, HIV
Cell Phone Reminders Intervention
This study will use a longitudinal, experimental design. Participants will be randomized to either the intervention or the control group.
- Conditions
- HAART Non-Adherence, HIV, HIV Infections
- Trial name
- NCT01049568
- Testing
- Cell Phone Intervention
- Where
- 5 sites in United States
- Volunteers
- 43 people
- Sponsor
- University of North Carolina, Chapel Hill
Hiv, Perinatal HIV Infection
Sexual Needs of Adolescents Living With HIV Since Childhood
To improve the knowdelge about the sexual health needs of perinatally HIV-infected adolescents living in France.
- Trial name
- SSVIH (NCT05206123)
- Testing
- Interview
- Where
- France
- Volunteers
- 27 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
HIV/AIDS
PHAT Life: Peer Versus Adult-Led HIV Prevention for Juvenile Offenders
This application proposes a 2-arm randomized controlled trial comparing the impact of PHAT Life on 350 13-17 year-old offenders' risky sex, STI, substance use, and theoretical mediators when delivered by Youth Representatives…
- Trial name
- PHATLife (NCT03555279)
- Testing
- PHAT Life: Preventing HIV/AIDS Among Teens--PS Arm, PHAT Life: Preventing HIV/AIDS Among Teens--YR Arm
- Where
- United States
- Volunteers
- 218 people, healthy volunteers welcome
- Sponsor
- University of Illinois Chicago
HIV Infections
Impact of Antiretroviral Therapy on Cardiac Biomarkers
Cardiovascular risk appears to be linked to some degree with inflammation. HIV medications have been linked with cardiovascular risk.
- Trial name
- NCT00641888
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- University of California, Davis
HIV Seronegativity, Linkage
Linkage of Transgender Individuals to PrEP
CCTG 602 is a multisite demonstration project to evaluate the effectiveness of facilitated linkage to PrEP using a community-based transgender PrEP outreach worker (T-POWr) versus standard of care (SOC).
- Trial name
- NCT03191474
- Testing
- T-POWr Intervention
- Where
- 2 sites in United States
- Volunteers
- 202 people, healthy volunteers welcome
- Sponsor
- University of California, San Diego
Acquired Immunodeficiency Syndrome, HIV Infections
Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women
The primary objective of this study is to evaluate the efficacy of a regimen containing elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (E/C/F/TDF) versus ritonavir (RTV)-boosted atazanavir (ATV/r) plus…
- Trial name
- WAVES (NCT01705574)
- Testing
- E/C/F/TDF, ATV, RTV
- Where
- 99 sites in United States, Belgium and 10 more
- Volunteers
- 583 people
- Sponsor
- Gilead Sciences
Mobile Health, Asthma
Implementing, a Mobile Health Application for HIV Infected and Uninfected Women With Co-morbidities in the Outpatient Setting
This is a pilot study conducted at the Bronx MWCCS Clinical Research Site in the Bronx, NY. We will recruit 60 individuals with coexisting asthma and/or Type 2 DM from this cohort.
- Conditions
- Mobile Health, Asthma, Diabetes Mellitus
- Trial name
- NCT04810260
- Testing
- Use mobile health app (WellXcel) to increase knowledge
- Where
- United States
- Volunteers
- 42 people
- Sponsor
- Montefiore Medical Center
HIV-facial Lipoatrophy
Artefill for the Treatment of HIV-associated Facial Lipoatrophy
Artefill is an injectable facial filler device that is currently approved by the FDA for the correction of nasolabial folds. This study seeks to examine the use of Artefill in the treatment of HIV associated facial lipoatrophy.
- Trial name
- NCT02009462
- Testing
- Artefill dermal filler
- Where
- United States
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Gerald Pierone, Jr. M.D.
HIV, HIV Infections
A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women
The purpose of this study is to study how changes in the body during pregnancy influence the blood levels of TMC114 (darunavir) and ritonavir taken together, darunavir and cobicistat taken as a fixed-dose combination, TMC125…
- Conditions
- HIV, HIV Infections, Pregnancy
- Trial name
- NCT00855335
- Testing
- Darunavir, Ritonavir, Etravirine
- Where
- 17 sites in United States, Puerto Rico
- Volunteers
- 77 people
- Sponsor
- Janssen Scientific Affairs, LLC
Meningitis, Cryptococcal, HIV Infections
Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
To evaluate the safety and effectiveness of fluconazole as an intravenous dose as initial treatment for acute cryptococcal meningitis followed by oral therapy in AIDS and non-AIDS patients.
- Trial name
- NCT00002040
- Testing
- Fluconazole
- Where
- 5 sites in United States
- Sponsor
- Pfizer
HIV Infections
Drug Interaction Study With Proton Pump Inhibitor
The purpose of this clinical research study is to assess the effect of omeprazole at 20 mg on the pharmacokinetics of atazanavir administered as atazanavir with ritonavir relative to atazanavir or atazanavir/ritonavir in the…
- Trial name
- NCT00357240
- Testing
- Atazanavir, Atazanavir/Ritonavir, Atazanavir/Ritonavir+Omeprazole
- Where
- United States
- Volunteers
- 56 people, healthy volunteers welcome
- Sponsor
- Bristol-Myers Squibb
HIV, AIDS
Social Network Intervention to Engage Out-of-Care PLH Into Treatment
Formative Research Phase (Months 1-6) The investigators will undertake qualitative formative studies to: (1) identify barriers to highly active antiretroviral therapy (HAART) and strategies currently used to engage PLH in care…
- Trial name
- NCT01825018
- Testing
- Social Network Leader Endorsement, HIV Counseling
- Where
- Russia
- Volunteers
- 721 people
- Sponsor
- Medical College of Wisconsin
HIV Infections
Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir
The purpose of this clinical trial is to characterize drug interactions between one medicinal herb widely used by HIV infected patients: Echinacea sp. and the protease inhibitor darunavir/ritonavir.
- Trial name
- NCT01046890
- Testing
- Echinacea
- Where
- Spain
- Volunteers
- 15 people
- Sponsor
- Germans Trias i Pujol Hospital
HIV Infection, Inflammation
Effect of Raltegravir on Endothelial Function in HIV-Infected Patients
Recent studies suggest that HIV patients are at increased risk for cardiovascular events; however, the mechanisms underlying this increased risk remain unclear.
- Conditions
- HIV Infection, Inflammation, Cardiovascular Disease, HIV Infections
- Trial name
- NCT00843713
- Testing
- raltegravir
- Where
- United States
- Volunteers
- 56 people
- Sponsor
- University of California, San Francisco
Substance-Related Disorders, Sexually Transmitted Diseases
Adolescent Drug and HIV Prevention in South Africa
The purpose of this trial is to test the effectiveness of a classroom-based prevention program (HealthWise: Learning Life Skills for Young Adults) to reduce the risk of HIV/AIDS and STIs, as well as substance use, among…
- Trial name
- NCT00336180
- Testing
- HealthWise South Africa curriculum
- Where
- South Africa
- Volunteers
- 7,695 people, healthy volunteers welcome
- Sponsor
- Penn State University
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.